Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii

Journal of Nanobiotechnology(2024)

引用 0|浏览7
暂无评分
摘要
Multidrug-resistant (MDR) Acinetobacter baumannii (A. baumannii) is a formidable pathogen responsible for severe intracranial infections post-craniotomy, exhibiting a mortality rate as high as 71
更多
查看译文
关键词
Nanoparticles,Blood–brain barrier,Multidrug-resistant Acinetobacter baumannii,Tigecycline,Intracranial infection
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要